Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal

Notified -

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound

Music Licensing, Inc. (OTC: SONGD) Acquires Prestigious Royalty-Generating IP Stake in "Goodnight Gotham" by Rihanna

Music Licensing, Inc. (OTC: SONGD) Receives Third Royalty Payment from Stake in Listerine "Mouthwash" Antiseptic

Exodus Movement, Inc. Announces Uplist to NYSE American Exchange

Matmerize, Inc. and CJ Biomaterials Partner to Utilize Innovative AI Technology to Advance Sustainable Polymer Solutions

Music Licensing, Inc. Reports Strong Fiscal Year 2023 Results

Music Licensing, Inc. (OTC: SONG) Secures Intellectual Property Rights for Listerine "Mouthwash" Antiseptic

The Sanborn Map Company, Inc. Expands Global Presence with Launch of Sanborn Geophysics, ULC

EANAN AL SAMMA (EANAN) and Jetoptera, Inc. partner to launch VTOL platforms powered by Fluidic Propulsive System™.

Safety Shot, Inc Hires Securities Litigation Attorney Mark R. Basile, Esq. and The Basile Law Firm P.C. - Dilution Funding and Short and Distort Experts

Zoom AI Companion hits one million meeting summaries milestone